Blueprint Medicines Corp (BPMC)

100.15 -1.19  -1.17% NASDAQ Oct 15, 16:00 100.20 +0.05  +0.05% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All BPMC News

News

View All Events

Events

Date Type Description
10/29/2021 Earnings Results Q3 2021 Earnings Results
10/29/2021 08:30 EST Earnings Calls Q3 2021 Earnings Call
07/29/2021 Earnings Results Q2 2021 Earnings Results
07/29/2021 08:30 EST Earnings Calls Q2 2021 Earnings Call
06/02/2021 16:00 EST AGM 2021 Annual General Meeting
04/29/2021 Earnings Results Q1 2021 Earnings Results
04/29/2021 08:30 EST Earnings Calls Q1 2021 Earnings Call
02/17/2021 Earnings Results Q4 2020 Earnings Results
02/17/2021 08:30 EST Earnings Calls Q4 2020 Earnings Call
10/29/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants that are drivers of cancer and proliferative disorders. Its other drug candidate is BLU 554 FOR Advanced Hepatocellular Carcinoma, and BLU-667 for Ret Mutations, Fusions, and Predicted Resistant Mutants.
  • URL: http://www.blueprintmedicines.com
  • Investor Relations URL: https://ir.blueprintmedicines.com
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Oct. 29, 2021
  • Last Earnings Release: Jul. 29, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
GNOM Global X Genomics & Biotechnology ETF 4.53%
IDNA iShares Genomics Immnlgy & Hlthcr ETF 3.99%
PBE Invesco Dynamic Biotech & Genome ETF 3.00%
BBP Virtus LifeSci Biotech Products ETF 2.34%
HRSGX Harbor Small Cap Growth Admin 1.94%
ETCHX Eventide Healthcare & Life Sciences C 1.91%
FTXH First Trust Nasdaq Pharmaceuticals ETF 1.76%
FBIOX Fidelity® Select Biotechnology 1.23%
DCCRX Delaware Small Cap Core R 1.03%
BTEC Principal Healthcare Innovators ETF 0.87%
FPHAX Fidelity® Select Pharmaceuticals Port 0.83%
PNASX Principal SmallCap Growth I R1 0.75%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.